These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19949425)

  • 1. Cardiovascular effects of leptin.
    Sweeney G
    Nat Rev Cardiol; 2010 Jan; 7(1):22-9. PubMed ID: 19949425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.
    Martin SS; Qasim A; Reilly MP
    J Am Coll Cardiol; 2008 Oct; 52(15):1201-10. PubMed ID: 18926322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leptin as a mediator between obesity and cardiac dysfunction].
    Karbowska J; Kochan Z
    Postepy Hig Med Dosw (Online); 2012 May; 66():267-74. PubMed ID: 22706112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin and cardiovascular diseases.
    Luo JD; Zhang GS; Chen MS
    Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology.
    Sharma V; McNeill JH
    Curr Vasc Pharmacol; 2005 Apr; 3(2):169-80. PubMed ID: 15853636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin, obesity and cardiovascular disease.
    Correia ML; Haynes WG
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):215-23. PubMed ID: 15202616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue, inflammation and endothelial dysfunction.
    Chudek J; Wiecek A
    Pharmacol Rep; 2006; 58 Suppl():81-8. PubMed ID: 17332676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin and cardiovascular diseases.
    Hou N; Luo JD
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Leptin in Cardiovascular Diseases.
    Poetsch MS; Strano A; Guan K
    Front Endocrinol (Lausanne); 2020; 11():354. PubMed ID: 32655492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin-induced endothelial dysfunction: a target for therapeutic interventions.
    Payne GA; Tune JD; Knudson JD
    Curr Pharm Des; 2014; 20(4):603-8. PubMed ID: 23688011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin and atherosclerosis.
    Beltowski J
    Atherosclerosis; 2006 Nov; 189(1):47-60. PubMed ID: 16580676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and the regulation of endothelial function in physiological and pathological conditions.
    Bełtowski J
    Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):168-78. PubMed ID: 21973116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.
    Knudson JD; Payne GA; Borbouse L; Tune JD
    Curr Hypertens Rep; 2008 Dec; 10(6):434-9. PubMed ID: 18959828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases.
    Dong M; Ren J
    Curr Pharm Des; 2014; 20(4):652-8. PubMed ID: 23688014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.
    Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin as a Mediator of Obesity-Induced Hypertension.
    Bell BB; Rahmouni K
    Curr Obes Rep; 2016 Dec; 5(4):397-404. PubMed ID: 27665107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity-hypertension: emerging concepts in pathophysiology and treatment.
    Mathew B; Patel SB; Reams GP; Freeman RH; Spear RM; Villarreal D
    Am J Med Sci; 2007 Jul; 334(1):23-30. PubMed ID: 17630587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics.
    Karmazyn M; Purdham DM; Rajapurohitam V; Zeidan A
    Trends Cardiovasc Med; 2007 Aug; 17(6):206-11. PubMed ID: 17662916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.